Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04468815 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT04468815 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 24 participants.
The verdict
NCT04468815, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to assess levels in blood plasma of BMS-986278 and the food effect in healthy participants.
Interventions
- DRUG Esomeprazole
- DRUG BMS-986278 Tablet
- DRUG BMS-986278 suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2020-07-10 |
| Est. Completion | 2020-10-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04468815
The ClinicalTrials.gov registry entry for NCT04468815 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Esomeprazole is the first listed.
NCT04468815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04468815 about?
NCT04468815 is a clinical study titled "A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)". The purpose of this study is to assess levels in blood plasma of BMS-986278 and the food effect in healthy participants.
What is the current status of trial NCT04468815?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2020-07-10. Estimated completion is 2020-10-07.
What interventions are being tested in trial NCT04468815?
The interventions under investigation include: Esomeprazole (DRUG), BMS-986278 Tablet (DRUG), BMS-986278 suspension (DRUG).
Who is sponsoring clinical trial NCT04468815?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.